Top Midday Decliners

MT NewswiresMar 27 14:48 ET

Scinai Immunotherapeutics Signs An Option Agreement To Acquire Rare Disease Company Pincell And Its Novel Antibody For Treating Severe Dermatological Conditions; No Financial Terms Of Transaction Disclosed; Files An Application For €12 Million Grant...

BenzingaMar 27 09:27 ET

Scinai Signs An Option Agreement To Acquire Rare Disease Company Pincell And Its Novel Antibody For Treating Severe Dermatological Conditions >SCNI

Dow JonesMar 27 09:25 ET

Scinai Signs $10M Standby Equity Agreement, Retains Control Over Stock Sales to Yorkville

BenzingaMar 5 07:33 ET

Press Release: SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

Dow JonesMar 5 07:30 ET

Scinai Immunotherapeutics Files to Sell 3.02M ADS for Holders

TipRanksMar 4 17:30 ET